Voltage-gated proton channels (HV1) are phylogenetically diverse, being distributed from unicellular marine life to humans. They have uniquely small unitary conductance but are perfectly selectivity for protons, which is essential considering the low H+ concentration in cells. HV1 channels are voltage activated and their voltage dependence is strongly regulated by the transmembrane pH gradient ( ), so that they extrude acid from cells. The HV1 channel protein is strikingly similar to the voltage-sensing domain of voltage-gated K+ and Na+ ?pH channels. Mammalian HV1 channels are dimers with a conduction pathway through each protomer (incredibly these gate cooperatively!). HV1 functions in humans are diverse, including phagocyte bacteria killing, airway pH regulation, basophil histamine release, sperm maturation, and B lymphocyte responses. Elevated HV1 expression exacerbates chronic lymphocytic leukemia, breast, and colon cancer metastasis, and contributes to brain damage from ischemic stroke. Indeed, recognition of the clinical importance of HV1 channels is rapidly expanding. In contrast, the molecular mechanisms that control HV channel function remain poorly understood. This makes development of rational HV1 channel targeted therapeutic interventions mechanistically blind and thus nearly impossible. Only one crystal structure exists (of a presumed closed state), and it has suspected flaws due to its being a chimera. Thus, the exposed parts of the channel (i.e. those assessable by aqueous therapeutics), especially when open, are very poorly defined. To overcome this knowledge barrier, we will identify clinically pertinent structure-functional attributes of HV1 gating and pH sensing using a combination of state-of-the-art electrophysiology, molecular biology, and protein biochemistry. We will test the following overall hypothesis: The clinically relevant pH sensing, permeation, and gating mechanisms of the H channel are functionally linked via multiple protonatable groups, V1 providing a redundancy that safeguards the essential physiological function of proton channels. By addressing this hypothesis our aims will systematically establish a strong mechanistic foundation that defines possible points of therapeutic intervention.
In Aim 1 we will determine the molecular mechanism that couples transmembrane pH gradient and HV1 channel gating. The unique ?pH dependence of gating is the single most important property of the HV1 channel and is central to all known HV1 functions, yet has eluded all efforts to understand its mechanism. Experiments will be guided by three novel mechanistic models that involve charges in the protein and protonation sites. By identifying the correct pH sensing mechanism, critical molecular components can be located.
Aim 2 focuses on understanding the gating mechanism of HV1, especially the location and solvent accessibility of residues in closed and open channels. We will study mutants with unique gating properties; model closed, intermediate, and open states using molecular dynamics (MD); and evaluate the role of dimerization in the responses of HV1 in phagocytes, sperm, and other cells. Identifying the key parts of the molecule involved in gating will enable regulating channel opening in health and disease.

Public Health Relevance

Voltage-gated proton channel proteins are found in many types of cells: they help white blood cells kill bacteria, sperm fertilize eggs, and other cells remain healthy. And, their dysfunction is associated with leukemia, breast cancer metastasis, autoimmune diseases, and brain damage in stroke. By discovering how proton channels work, and which of their parts are accessible to drug binding, this project is essential to enable the design of drugs to control their activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM121462-01A1
Application #
9379711
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Nie, Zhongzhen
Project Start
2017-09-18
Project End
2019-06-30
Budget Start
2017-09-18
Budget End
2019-06-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Thomas, Sarah; Cherny, Vladimir V; Morgan, Deri et al. (2018) Exotic properties of a voltage-gated proton channel from the snail Helisoma trivolvis. J Gen Physiol 150:835-850
DeCoursey, Thomas E (2018) Voltage and pH sensing by the voltage-gated proton channel, HV1. J R Soc Interface 15:
DeCoursey, Thomas E (2018) Gating currents indicate complex gating of voltage-gated proton channels. Proc Natl Acad Sci U S A 115:9057-9059
Cherny, Vladimir V; Morgan, Deri; Thomas, Sarah et al. (2018) Histidine168 is crucial for ?pH-dependent gating of the human voltage-gated proton channel, hHV1. J Gen Physiol 150:851-862
DeCoursey, Thomas E (2017) Rebuttal from Thomas E. DeCoursey. J Physiol 595:6801
DeCoursey, Thomas E (2017) CrossTalk proposal: Proton permeation through HV 1 requires transient protonation of a conserved aspartate in the S1 transmembrane helix. J Physiol 595:6793-6795